Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
about
Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysisAntidepressants for depression during pregnancyThe Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Antidepressants, anxiolytics, and hypnotics in pregnancy and lactationA patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial.Antidepressant use in pregnancy: a critical review focused on risks and controversiesMonoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.Prenatal antidepressant exposure: clinical and preclinical findings.Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.Continuing medical education: SSRIs and pregnancy.Prenatal exposure to serotonin reuptake inhibitors: a case reportAntidepressant use in pregnancy and the risk of cardiac defectsSelective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.Antidepressant use in pregnant and postpartum womenExposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysisLength of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesThe Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy.Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.Depression and antidepressants in pregnancy: molecular and psychosocial mechanisms affecting offspring's physical and mental healthPrevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort studyEarly-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.Use of prescribed drugs among primiparous women: an 11-year population-based study in DenmarkOntogeny and regulation of the serotonin transporter: providing insights into human disorders.Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxietySelective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.Case 1: A newborn in distress.Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 1: Literature review.Women's perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey.
P2860
Q21198704-A24BF9B5-1D68-4B2E-AE73-760B8D35FE47Q24200798-E490C9FF-1639-4E7F-9C72-A9FDB6FCC39BQ26741187-4C5AC4A6-6AFD-4982-A4F2-E053CB055561Q26795384-FF89D6A2-AEEC-420B-B2CE-370CE6801339Q27334448-7B3C6C5B-18B7-4F52-8400-DC7A24DA1B73Q28281407-284B0484-A190-4198-BCB1-245055C4AB76Q30395001-FF60CE90-2126-46CC-A7A5-C1EA41CCA8D7Q30415540-992DCB9E-E1B7-4137-BA0A-4DB89DE383F9Q30855293-824DF67F-7C53-43D4-8CA7-4F6CAB059572Q33521786-A7463ACC-C2B4-47DA-8F55-C32D85904271Q33671166-E2C281E6-B92B-487C-A8CA-895A9F0617DDQ33763631-17537368-96DE-4694-A39E-5D1A709A2630Q33775616-3F4F3A32-B84A-4AB5-97DB-B579CBDC080AQ33801507-29374E5A-B3E3-42BA-8EB8-456FD44D54A9Q33841097-FDE5A72F-DEA8-4D25-9084-992D3C3CAAF7Q34047430-8559F9B4-9EBE-4FF4-81F3-5D6071A6ACF9Q34062619-C6891765-C266-4761-BE6F-4A5FAFEBC7DBQ34068023-F48D56BA-6FD0-45BA-B2FA-21209704AA74Q34073546-AC0DE7F5-6A98-4DCA-9EDD-7640534FEAAFQ34144128-2A487B23-6957-4781-95E3-05985B366E74Q34178991-BE6ACABE-994C-429E-8AC8-9F4675458234Q34237681-24BE23F3-26B1-44D9-83FD-230D0D45F2FEQ34240630-15E59E7C-D522-4532-8C9D-7EF9B7D24C36Q34250131-D0F2F650-E0CC-464D-B879-8824617CBDE5Q34270366-C1748F09-9246-4FCE-A38C-574B05932215Q34467757-22759061-0D98-40B4-A5DE-75C69BD9D27DQ34483257-73C18958-E117-4BDB-902F-E1FFFFA06E39Q34516341-6E760BDA-50F5-4690-8777-0D93FD29F6E0Q34675901-5E9DDA9C-CABE-4D9B-A784-6ECB02BC5C65Q34702282-F878A6B2-9B22-43F9-9213-BC65A18B70A7Q34714284-62FB9FFC-3310-4E9F-9EAA-ED20B20B646FQ34987204-48856B3B-801F-44CA-B2E5-0B79B7B47293Q35090255-DD80F844-16F6-42C4-8BDA-9F576521E964Q35132422-243FD769-5A3A-471A-B4B4-7B2F20638C05Q35252134-65CCD900-B873-4F13-B9A3-7B7A39CC2F11Q35541040-886560AC-2A5A-43F7-9AC9-4BF58DC08B78Q35572617-D47367A9-E942-481D-B049-9A054AB5FDC9Q35608913-9EF98046-60FD-4E6F-A869-7B517BF27DF1Q35640425-0907650C-08F2-4B8F-AF99-1ED69484C4E5Q35691721-DA09C4E9-1E8C-40C0-9D75-585EFFC0E95D
P2860
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Selective serotonin reuptake i ...... population based cohort study.
@en
Selective serotonin reuptake i ...... population based cohort study.
@nl
type
label
Selective serotonin reuptake i ...... population based cohort study.
@en
Selective serotonin reuptake i ...... population based cohort study.
@nl
prefLabel
Selective serotonin reuptake i ...... population based cohort study.
@en
Selective serotonin reuptake i ...... population based cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Selective serotonin reuptake i ...... population based cohort study.
@en
P2093
Bodil Hammer Bech
Mogens Vestergaard
Tine Brink Henriksen
P2860
P356
10.1136/BMJ.B3569
P407
P577
2009-09-23T00:00:00Z